Hospital and ER admissions | ||
---|---|---|
N = 100,902 | ||
n | Proportion | |
Age (y) | ||
Mean (SD) | 52.39 (19.32) | |
Median (IQR) | 52 (67–36) | |
< 17 year | 8238 | 8.20% |
18–34 | 20,822 | 20.60% |
35–49 | 20,661 | 20.50% |
50–64 | 23,821 | 23.60% |
65–79 | 18,316 | 18.20% |
≥ 80 | 9044 | 9.00% |
Sex | ||
Men | 49,331 | 48.90% |
Women | 51,172 | 50.70% |
Race | ||
White | 58,655 | 58.10% |
Black | 18,538 | 18.40% |
Other | 23,709 | 23.50% |
Ethnicity | ||
Hispanic | 43,266 | 42.9% |
Non-hispanic | 53,343 | 52.90% |
Other or unknown | 4293 | 4.30% |
Hospital region | ||
Midwest | 8309 | 8.20% |
Northeast | 20,827 | 20.60% |
South | 40,448 | 40.10% |
West | 31,318 | 31.00% |
Hospital beds, no | ||
1–99 | 1024 | 1.00% |
100–199 | 825 | 0.80% |
200–299 | 2751 | 2.70% |
300–499 | 7983 | 7.90% |
500–999 | 20,972 | 20.80% |
> 1000 | 67,347 | 66.70% |
CCI | ||
Charlson Comorbidity Index mean (SD) | 1.217 (2.02) | |
0 | 55,848 | 55.30% |
1–4 | 36,072 | 35.70% |
≥ 5 | 8982 | 8.90% |
Charlson comorbidities | ||
Myocardial infarction | 4060 | 4.00% |
Congestive heart Failure | 8269 | 8.20% |
Peripheral vascular disease | 2995 | 3.00% |
Cerebrovascular disease | 3240 | 3.20% |
Dementia | 5597 | 5.50% |
COPD | 13,865 | 13.70% |
Rheumatological disease | 1458 | 1.40% |
Peptic ulcer disease | 475 | 0.50% |
Mild Liver disease | 3517 | 3.50% |
DM with no complications | 23,411 | 23.20% |
DM with chronic complications | 7842 | 7.80% |
Hemiplegia/ Paraplegia | 787 | 0.80% |
Kidney disease | 10,345 | 10.30% |
Any malignancy, including leukemia or lymphoma | 2389 | 2.40% |
Moderate or severe liver disease | 711 | 0.70% |
Metastatic solid tumor | 605 | 0.60% |
AIDS/ HIV | 428 | 0.40% |
Hypertension | 31,258 | 31.00% |
Hyperlipidemia | 17,549 | 17.40% |
Concomitant GI conditions | ||
Acute liver failure | 444 | 0.40% |
Chronic GERD | 7541 | 7.50% |
GI malignancy, ALL | 376 | 0.40% |
GI malignancy, esoph/ stomach/colon/liver | 265 | 0.30% |
IBD (UC + chrons) | 316 | 0.30% |
Celiac disease | 36 | 0.00% |
Length of stay | ||
Mean (SD) | 6.83 days (15.73) | |
Median (IQR) | 2 (8) | |
Mortality | ||
Total in hospital mortality | 8574 | 8.5% |
Severe complications | ||
ARDS | 4135 | 4.1% |
Sepsis | 16,145 | 16.0% |
AKI | 14,782 | 14.6% |
VTE | 1559 | 1.5% |
Chronic ischemic heart disease | 8574 | 8.4% |
Respiratory failure | 27,829 | 27.6% |
Use of mechanical ventilation | 3177 | 3.1% |
GI specific complications | ||
GI bleeding (GI Hem) | 2000 | 1.98% |
Intestinal ischemia | 37 | * |
Pancreatitis | 554 | * |
Acute liver injury | 444 | * |
Dysphagia | 2899 | 2.87% |
Pseudo obstruction/Ogilvie | 13 | * |